Response to commentary re: Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's oncology group.

Autor: Singla N; Departments of Urology and Oncology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Wong J; University of Texas Southwestern Medical School, Dallas, TX, USA., Singla S; Pediatric Specialists of Virginia, Fairfax, VA, USA., Krailo M; University of Southern California, Los Angeles, CA, USA; Children's Oncology Group, USA., Huang L; Children's Oncology Group, USA., Shaikh F; The Hospital for Sick Children, Toronto, Canada., Billmire D; Indiana University, Bloomington, IN, USA., Rescorla F; Indiana University, Bloomington, IN, USA., Ross J; Rainbow Babies and Children's Hospital, Cleveland, OH, USA., Dicken B; University of Alberta, Canada., Amatruda JF; University of Southern California, Los Angeles, CA, USA; Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA., Frazier AL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Bagrodia A; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: bagrodia@health.ucsd.edu.
Jazyk: angličtina
Zdroj: Journal of pediatric urology [J Pediatr Urol] 2022 Aug; Vol. 18 (4), pp. 513-514. Date of Electronic Publication: 2022 Jul 08.
DOI: 10.1016/j.jpurol.2022.06.027
Databáze: MEDLINE